By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Atara Biotherapeutics 

2659 Townsgate Road
Suite 236
Thousand Oaks  California  91361  U.S.A.
Phone: 805-309-0888 Fax: n/a



Company News
Atara Biotherapeutics (ATRA) To Present At The J.P. Morgan Healthcare Conference 1/9/2015 8:15:27 AM
Atara Biotherapeutics (ATRA) Announces Third Quarter 2014 Operating Results 11/12/2014 8:00:26 AM
Atara Biotherapeutics (ATRA)' Collaborating Investigators To Present Data At The American Society of Hematology Annual Meeting 2014 11/6/2014 10:36:41 AM
Atara Biotherapeutics (ATRA) Doses First Patient In Phase 1 Clinical Study Of STM 434, An Activin Inhibitor 10/22/2014 7:15:43 AM
Nasdaq Welcomes Atara Biotherapeutics (ATRA) To The Nasdaq Stock Market 10/16/2014 10:38:54 AM
Atara Biotherapeutics (ATRA) To Ring The Nasdaq Stock Market Opening Bell In Celebration Of IPO 10/16/2014 7:37:06 AM
Atara Biotherapeutics (ATRA) Prices IPO Below The Range At $11 A Share 10/16/2014 7:34:51 AM
Atara Biotherapeutics Announces Immunotherapy Alliance With Memorial Sloan-Kettering Cancer Center 9/23/2014 9:08:10 AM
SoCal's Atara Biotherapeutics IPO Delayed By New Test Results 7/24/2014 7:55:23 AM
Amgen (AMGN) Spinoff Atara Biotherapeutics Hikes IPO Target From $50 Million To $92 Million 7/11/2014 8:16:49 AM